
Four drugs firms and a private equity group have were fined more than £35m by the competition watchdog for colluding to restrict the supply of an anti-nausea tablet (Lauren Hurley/PA)
(Picture: PA Archive)British healthcare company Alliance Pharma suffered a major blow today after it announced boss Peter Butterfield could lose his job as company director following an investigation by the UK competition watchdog.
Butterfield, who has been CEO since 2018, is set to face a Competition Disqualification Order by the Competition and Markets Authority for his involvement in alleged anti-competitive practices in relation to the sale of prescription anti-nausea tablets.